REFERENCES


  1. Scott E et al.  “Positive Management of persistent pain”. SPHERE: a national mental health project. Educational Health Solutions, Vic, 2006.
  2. Nicholas MK & Molloy AR. Cognitive behavioural therapy for chronic pain patients. Medicine Today Pain Management Supplement. August 2003: 12-17.
  3. Goucke CR. Clinical update: The management of persistent pain. MJA 2003; 178(9): 444-447.
  4. NSW Therapeutic Assessment Group (TAG). “General Principles: rational use of opioids in chronic or recurrent non-malignant pain”. Dec 2002. http://www.ciap.health.nsw.gov.au/nswtag/guidelines.html
  5. NSW Health. “Pain – chronic pain and its management: Information for Medical Practitioners”. NSW Health website. http://health.nsw.gov.au/public health/psb/chronic_pain
  6. Australian Medicines Handbook www.amh.net.au
  7. Australian Pain Society. Position Statement: The role of the psychologist in the management of persistent pain. November 2002. http://www.apsoc.org.au
  8. The Australian Government Department of Health & Ageing website http://www.health.gov.au
  9. WHO. Cancer Pain Relief, World Health Organisation. Geneva 1986: 51.
  10. Therapeutic Guidelines: Rheumatology. Therapeutic Guidelines Limited. Melbourne, Australia. Version 1, 2006
  11. Grainger R & Cicuttini FM. Medical management of osteoarthritis of the knee and hip joints. MJA 2004; 180(5): 232-236.
  12. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Art Rheum 2000; 43: 1905-1915.
  13. McColl GJ. Pharmacological therapies for the treatment of osteoarthritis. MJA 2001; 175: S108-S111.
  14. National Prescribing Service (NPS) Limited. Prescribing Practice Review 22: Optimising safe and effective use of analgesics in musculoskeletal pain. July 2003.
  15. Zhang W et al. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised, controlled trials. Ann Rheum Dis 2004; 63: 901-907.
  16. Wegman A et al. Nonsteroidal antiinflammatory drugs or acetaminophen for osteoarthritis of the hip or knee? A systematic review of evidence and guidelines. J Rheumatol 2004; 31: 344-354.
  17. Therapeutic Guidelines: Analgesic. Therapeutic Guidelines Limited. Melbourne, Australia. Version 5, 2007.
  18. National Prescribing Service Limited. Prescribing Practice Review 35: Analgesic choices in persistent pain. Sept 2006. http://www.nps.org.au. [Accessed Jan 2008].
  19. National Prescribing Service Limited. NPS News 47: Analgesic options for pain relief. Aug 2006. http://www.nps.org.au. [Accessed Jan 2008].
  20. National Prescribing Service Limited. Fact Sheet: Diclofenac and cardiovascular risk. Sept 2006. http://www.nps.org.au/site.php?page=1 [Accessed Jan 2008].
  21. National Prescribing Service Limited. Prexige withdrawal. Aug 2007. http://www.nps.org.au/site.php?page=2&content=/resources/content/prexige_withdrawn_rel.html) [Accessed Dec 2007).
  22. Australian Medicines Handbook 2008. AMH Pty Ltd. Australia, 2008
  23. National Prescribing Service (NPS) Limited Clinical Audit. Analgesics in persistent pain. 2006.
  24. Moore RA et al. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. Br Med J 1998; 316: 333-338.
  25. Toda Y et al. Changes in body fat, but not body weight or metabolic correlates of obesity, is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program. J Rheumatol 1998; 25: 2181-86.
  26. Schnitzer TJ et al. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain. Arthritis Rheum 1999; 42(7): 1370-1377.
  27. NSW Therapeutic Assessment Group (TAG). “General principles: rational use of opioids in chronic or recurrent non-malignant pain”. December 2002.
  28. World Health Organisation (WHO). Cancer Pain Relief, World Health Organisation. Geneva 1986:51.
  29. Tramal Approved Product Information.
  30. Desmeules JA. The tramadol option. Eur J Pain 2000; 4(Suppl A): 15-21. Weekes L. Glucosamine
  31. Po ALW, Zhang WY. Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol. BMJ 1997; 315: 1564-71.
  32. Moore A et al Single dose paracetamol (acetaminophen), with and without codeine, for postoperative pain. Cochrane Database of Systematic Reviews 1998, Issue 4.
  33. Goucke CR. Clinical update: The management of persistent pain. MJA 2003; 178(7): 951-79.
  34. Better Health Channel – Pain management fact sheet. See http://betterhealth.vic,gov.au
  35. Goucke R. Management of chronic non-cancer pain. Medical Observer 2008; (January):23-26.
  36. CM. “Sydney Patients among first to be implanted with new pain device”. Consult magazine May-July 2007; 1: 6.
  37. Namaka M et al. A treatment algorithm for neuropathic pain. Clin Ther 2004; 26(7): 951-79.
  38. Bouhassira D et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114(1-2): 29-36.
  39. Finnerup et al. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 2005; 118(3): 289-305.